Fig. 1From: Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populationsAssociations of genetically proxied angiotensin-converting-enzyme inhibitors (ACEIs), beta blockers (BBs), and calcium channel blockers (CCBs) with mental disordersBack to article page